Table:
begin	end	state
1	237	non-cytoplasmic
238	258	transmembrane
259	269	cytoplasmic
270	293	transmembrane
294	304	non-cytoplasmic
305	331	transmembrane
332	350	cytoplasmic
351	371	transmembrane
372	382	non-cytoplasmic
383	404	transmembrane
405	415	cytoplasmic
416	446	transmembrane
447	464	non-cytoplasmic
465	484	transmembrane
485	490	cytoplasmic
491	513	transmembrane
514	522	non-cytoplasmic
523	553	transmembrane
554	565	cytoplasmic

Input:
>WP_007699731.1 NCBI__GCF_001277175.1:WP_007699731.1
MKTLLIIEPGCGQARAYMAKTLLGAAAQKAQLELTDNPNDAELAIVIGSAVPADASLNGK
KVYLGDINRAVAHPELFLSEAKSHAAAYSAPAAAAPAASANASGPKRIVAVTACPTGVAH
TFMAAEAIETEAKKRGWWVKVETRGSVGAGNAITPEEVAQADLVIVAADIEVDLAKFAGK
PMYRTSTGLALKKTAQEFDKAVAEAKPYQPAGAGAAATDKKEQGGAGPYRHLLTGVSYML
PMVVAGGLLIALSFVFGIEAFKQEGTLAAALMKIGGGSAFALMVPVLAGYIAFSIADRPG
LTPGLIGGMLAVSTGSGFIGGIIAGFLAGYVAKAISGKVKLPQSMEALKPILIIPLFSSL
IVGLAMIYVIGTPVAKILAGLTAWLQSMGTANAVLLGAILGAMMCTDMGGPVNKAAYAFG
VGLLSSQVYAPMAAIMAAGMVPPLAMGIATLVARRKFDKGQQEGGKAALVLGLCFISEGA
IPFAARDPMRVIPCCIAGGALTGAISMAIGAKLMAPHGGLFVLLIPGAISPVLGYLLAIV
AGSLLAGLVYAFLKRPESELAAKAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server